Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel
The Pharma Data
OCTOBER 27, 2020
Food and Drug Administration (FDA). Clinical laboratories can process thousands of samples each day for less than $10 per sample running the assay on a single MassARRAY instrument, making it one of the highest throughput SARS-CoV-2 tests available under the Emergency Use Authorization program. SAN DIEGO , Oct. SOURCE Agena Bioscience.
52 
Let's personalize your content